Assessing NEDA in pediatric-onset MS

Specialists have investigated the assessment of No Evidence of Disease Activity (NEDA) in pediatric-onset MS.

Citing a lack of data regarding the prevalence of NEDA in pediatric-onset MS cases, researchers from the Cleveland Clinic Mellen Center, in Cleveland, Ohio, USA, performed retrospective analyses of 913 patients (symptom onset before the age of 18 years), using the Pediatric Multiple Sclerosis and other Demyelinating Diseases Database (PedMSDD).